The Progeria Research Foundation seeks letters of intent from qualified progeria researchers who are working on highly translational aspects of progeria research. Projects should lead to clinical treatment trials within 5 years; cover the development of gene and cell-based therapies; and the assessment of the natural history of disease that may be important in developing outcome measures during trials. Applicants should have faculty appointments in a US tax-exempt institution or their international equivalents. Applicants may apply for up to 75,000 USD/year for 1-2 years.
Letters of intent are due on January 3, 2023 and invited full applications are due on February 13, 2023.